BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 23855560)

  • 1. Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass.
    Dunlop JL; Vandal AC; de Zoysa JR; Gabriel RS; Haloob IA; Hood CJ; Matheson PJ; McGregor DO; Rabindranath KS; Semple DJ; Marshall MR
    BMC Nephrol; 2013 Jul; 14():149. PubMed ID: 23855560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the Myocardial Microinjury and Cardiac Remodeling Extension Study in the Sodium Lowering in Dialysate trial (Mac-SoLID study).
    Dunlop JL; Vandal AC; de Zoysa JR; Gabriel RS; Gerber LM; Haloob IA; Hood CJ; Irvine JH; Matheson PJ; McGregor DO; Rabindranath KS; Schollum JB; Semple DJ; Marshall MR
    BMC Nephrol; 2014 Jul; 15():120. PubMed ID: 25047825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Low-Sodium versus Conventional Sodium Dialysate on Left Ventricular Mass in Home and Self-Care Satellite Facility Hemodialysis Patients: A Randomized Clinical Trial.
    Marshall MR; Vandal AC; de Zoysa JR; Gabriel RS; Haloob IA; Hood CJ; Irvine JH; Matheson PJ; McGregor DOR; Rabindranath KS; Schollum JBW; Semple DJ; Xie Z; Ma TM; Sisk R; Dunlop JL
    J Am Soc Nephrol; 2020 May; 31(5):1078-1091. PubMed ID: 32188697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of a multi-centre randomised controlled trial of individualised cooled dialysate to prevent left ventricular systolic dysfunction in haemodialysis patients.
    Odudu A; Eldehni MT; Fakis A; McIntyre CW
    BMC Nephrol; 2012 Jun; 13():45. PubMed ID: 22720738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass.
    Dunlop JL; Vandal AC; de Zoysa JR; Gabriel RS; Haloob IA; Hood CJ; Matheson PJ; McGregor DO; Rabindranath KS; Semple DJ; Marshall MR
    BMC Nephrol; 2015 Aug; 16():120. PubMed ID: 26248851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifiable variables affecting interdialytic weight gain include dialysis time, frequency, and dialysate sodium.
    Thomson BK; Dixon SN; Huang SH; Leitch RE; Suri RS; Chan CT; Lindsay RM
    Hemodial Int; 2013 Oct; 17(4):576-85. PubMed ID: 23782770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low versus high dialysate sodium concentration on blood pressure and endothelial-derived vasoregulators during hemodialysis: a randomized crossover study.
    Inrig JK; Molina C; D'Silva K; Kim C; Van Buren P; Allen JD; Toto R
    Am J Kidney Dis; 2015 Mar; 65(3):464-73. PubMed ID: 25530107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Hecking M; Karaboyas A; Saran R; Sen A; Hörl WH; Pisoni RL; Robinson BM; Sunder-Plassmann G; Port FK
    Am J Kidney Dis; 2012 Feb; 59(2):238-48. PubMed ID: 21944663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated individualization of dialysate sodium concentration reduces intradialytic plasma sodium changes in hemodialysis.
    Ságová M; Wojke R; Maierhofer A; Gross M; Canaud B; Gauly A
    Artif Organs; 2019 Oct; 43(10):1002-1013. PubMed ID: 30939213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialysate sodium, serum sodium and mortality in maintenance hemodialysis.
    Mc Causland FR; Brunelli SM; Waikar SS
    Nephrol Dial Transplant; 2012 Apr; 27(4):1613-8. PubMed ID: 21891777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of nocturnal hemodialysis compared to conventional hemodialysis on change in left ventricular mass: rationale and study design of a randomized controlled pilot study.
    Walsh M; Manns BJ; Klarenbach S; Quinn R; Tonelli M; Culleton BF
    BMC Nephrol; 2006 Feb; 7():2. PubMed ID: 16504054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling.
    Chan CT; Greene T; Chertow GM; Kliger AS; Stokes JB; Beck GJ; Daugirdas JT; Kotanko P; Larive B; Levin NW; Mehta RL; Rocco M; Sanz J; Yang PC; Rajagopalan S;
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2106-16. PubMed ID: 23970131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dialysate to serum sodium (Na
    Raimann JG; Ficociello LH; Usvyat LA; Zhang H; Pacelli L; Moore S; Sheppard P; Xiao Q; Wang Y; Mullon C; Balter P; Sullivan T; Kotanko P
    BMC Nephrol; 2018 Apr; 19(1):75. PubMed ID: 29609536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre to post-dialysis plasma sodium change better predicts clinical outcomes than dialysate to plasma sodium gradient in quotidian hemodialysis.
    Thomson BK; Huang SH; Leitch RE; Dixon S; Heidenheim P; Suri RS; Chan CT; Lindsay RM
    Hemodial Int; 2013 Oct; 17(4):548-56. PubMed ID: 23551488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes (DOMESTICO): rationale and design.
    van Eck van der Sluijs A; Bonenkamp AA; Dekker FW; Abrahams AC; van Jaarsveld BC;
    BMC Nephrol; 2019 Sep; 20(1):361. PubMed ID: 31533665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients: a randomized controlled trial (ETECAR-HD).
    Dörr K; Kammer M; Reindl-Schwaighofer R; Lorenz M; Loewe C; Marculescu R; Erben R; Oberbauer R
    Trials; 2019 Oct; 20(1):601. PubMed ID: 31651370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Predialysis Serum Sodium Level Modifies the Effect of Hemodialysis Frequency on Left-Ventricular Mass: The Frequent Hemodialysis Network Trials.
    Raimann JG; Chan CT; Daugirdas JT; Depner T; Greene T; Kaysen GA; Kliger AS; Kotanko P; Larive B; Beck G; Lindsay RM; Rocco MV; Chertow GM; Levin NW;
    Kidney Blood Press Res; 2021; 46(6):768-776. PubMed ID: 34644706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing complications during hemodialysis using gradient ultrafiltration with gradient sodium dialysate.
    Meers C; Toffelmire EB; McMurray M; Hopman W
    ANNA J; 1999 Oct; 26(5):495-500; discussion 501, 505. PubMed ID: 10776077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solute kinetics with short-daily home hemodialysis using slow dialysate flow rate.
    Kohn OF; Coe FL; Ing TS
    Hemodial Int; 2010 Jan; 14(1):39-46. PubMed ID: 19758296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysate Sodium: Rationale for Evolution over Time.
    Flythe JE; Mc Causland FR
    Semin Dial; 2017 Mar; 30(2):99-111. PubMed ID: 28066913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.